Multicentric Castleman Disease (MCD) Latest Advances

Dysregulated lymphocyte localization in idiopathic multicentric Castleman disease.

Journal: bioRxiv : the preprint server for biology

Published: December 25, 2025

A Placebo-Controlled Exploratory Trial of Sirolimus for Tocilizumab-Resistant Idiopathic Multicentric Castleman Disease: Early Termination and Long-Term Extension Results Based on Descriptive Results From Two Patients.

Journal: Cureus

Published: December 01, 2025

Diagnostic and therapeutic challenges in hyaline-vascular idiopathic multicentric Castleman disease: A case report.

Journal: The Journal of international medical research

Published: October 23, 2025

Idiopathic Multicentric Castleman Disease-TAFRO: A Potentially Curable Disease?

Journal: American journal of hematology

Published: September 16, 2025

Successful tocilizumab monotherapy for multicentric Castleman disease complicated by rheumatoid arthritis and Sjögren's disease: a case-based literature review.

Journal: Immunological medicine

Published: August 14, 2025

Erratum: Lossos C, Brown J, Sheikhbahaei S, et al. Idiopathic multicentric Castleman disease - TAFRO results in high levels of mTOR activator SVEP1, tissue factor, and endotheliopathy. Blood Vessels Thromb Hemost. 2024;1(2):100006.

Journal: Blood vessels, thrombosis & hemostasis

Published: August 06, 2025

Striking effectiveness of siltuximab-based treatment in refractory idiopathic multicentric Castleman disease resembling IgG4-related disease.

Journal: Journal of chemotherapy (Florence, Italy)

Published: August 06, 2025

A case of KSHV/HHV8-positive large B-cell lymphoma in a background of HIV-negative KSHV/HHV8-positive Multicentric Castleman disease.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: August 04, 2025

Diagnostic Challenges in HHV-8-Associated Multicentric Castleman Disease in a Patient with Prior Kaposi Sarcoma.

Journal: Dermatopathology (Basel, Switzerland)

Published: July 27, 2025

Idiopathic multicentric Castleman disease resembling autoimmune diseases: A case report.

Journal: Medicine

Published: July 23, 2025

Use of tocilizumab to treat IgA nephropathy complicated by idiopathic multicentric Castleman disease: a case report.

Journal: BMC nephrology

Published: July 18, 2025

Potential Link Between COVID-19 Infection/Vaccination and the Onsets of TAFRO Syndrome and Idiopathic Multicentric Castleman Disease.

Journal: Immunology letters

Published: July 16, 2025